These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8970515)

  • 1. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.
    Mozley PD; Kim HJ; Gur RC; Tatsch K; Muenz LR; McElgin WT; Kung MP; Mu M; Myers AM; Kung HF
    J Nucl Med; 1996 Dec; 37(12):1965-70. PubMed ID: 8970515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.
    Mozley PD; Stubbs JB; Kim HJ; McElgin W; Kung MP; Meegalla S; Kung HF
    J Nucl Med; 1996 Jan; 37(1):151-9. PubMed ID: 8543985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopamine transporter imaging in nonhuman primates with iodine-123-IPT SPECT.
    Malison RT; Vessotskie JM; Kung MP; McElgin W; Romaniello G; Kim HJ; Goodman MM; Kung HF
    J Nucl Med; 1995 Dec; 36(12):2290-7. PubMed ID: 8523122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
    Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
    J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
    Tatsch K; Schwarz J; Mozley PD; Linke R; Pogarell O; Oertel WH; Fieber RS; Hahn K; Kung HF
    Eur J Nucl Med; 1997 Apr; 24(4):415-21. PubMed ID: 9096093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years.
    Chouker M; Tatsch K; Linke R; Pogarell O; Hahn K; Schwarz J
    Nucl Med Commun; 2001 Jun; 22(6):721-5. PubMed ID: 11403185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age on dopamine transporters in healthy humans.
    Mozley PD; Acton PD; Barraclough ED; Plössl K; Gur RC; Alavi A; Mathur A; Saffer J; Kung HF
    J Nucl Med; 1999 Nov; 40(11):1812-7. PubMed ID: 10565775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine transporters and cognitive functioning in healthy men and women.
    Mozley LH; Gur RC; Mozley PD; Gur RE
    Am J Psychiatry; 2001 Sep; 158(9):1492-9. PubMed ID: 11532737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
    Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
    J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
    Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
    J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT.
    Bonab AA; Fischman AJ; Alpert NM
    J Nucl Med; 2000 Jun; 41(6):1086-92. PubMed ID: 10855640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification analysis of 123I-IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template.
    Juh R; Pae CU; Lee CU; Kim J; Moon D; Suh T; Choe B
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):18-28. PubMed ID: 16472355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
    Eisensehr I; Linke R; Tatsch K; Kharraz B; Gildehaus JF; Wetter CT; Trenkwalder C; Schwarz J; Noachtar S
    Sleep; 2003 Aug; 26(5):507-12. PubMed ID: 12938802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT.
    Ichise M; Ballinger JR; Tanaka F; Moscovitch M; St George-Hyslop PH; Raphael D; Freedman M
    J Nucl Med; 1998 Sep; 39(9):1511-8. PubMed ID: 9744333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.